Real-World Analysis of the Efficacy of Rebiopsy and EGFR Mutation Test of Tissue and Plasma Samples in Drug-Resistant Non-Small Cell Lung Cancer

DOI: 10.3349/ymj.2019.60.6.525

Keywords: Non-small cell lung cancer, EGFR T790M, rebiopsy, osimertinib, liquid biopsy

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text